Related Experiment Videos
Tumour-suppressor genes in prostatic oncogenesis: a positional approach
R Bookstein1, G S Bova, D MacGrogan
1Canji Inc., San Diego, CA 92121, USA.
British Journal of Urology
|March 1, 1997
Summary
Researchers investigated genetic alterations in prostate cancer, identifying a novel gene, N33, on chromosome 8p22. This gene is silenced by methylation in colorectal cancers, suggesting its potential role in oncogenesis.
Area of Science:
- Oncology
- Human Genetics
- Molecular Biology
Background:
- Prostate cancer development involves genetic alterations like mutation, methylation, and aneuploidy.
- Genetic events in prostate oncogenesis, especially in early stages, remain poorly understood.
- Frequent allelic losses on chromosome 8p suggest novel tumor suppressor loci in prostate cancer.
Purpose of the Study:
- To identify novel genetic targets in prostate cancer using a positional approach.
- To investigate allelic loss mapping of chromosome 8p and physical mapping of 8p22.
- To characterize genes within a frequently deleted region on chromosome 8p22.
Main Methods:
- Positional cloning and allelic-loss mapping of chromosome 8p.
- Physical mapping of chromosome band 8p22.
- Detailed examination of expressed sequences within a 730-970 kb homozygous deletion.
- Analysis of gene silencing mechanisms, including methylation.
Main Results:
- A homozygous somatic deletion on chromosome 8p22 was identified in a prostate cancer metastasis.
- A novel gene, N33, was discovered within this deleted region.
- N33 was found to be silenced by methylation in colon cancer cell lines and primary colorectal tumors.
Conclusions:
- Novel genetic alterations, including deletions and gene silencing, are implicated in prostate cancer.
- The N33 gene, silenced by methylation, is a potential target for further investigation in both prostate and colorectal cancers.
- Continued characterization of chromosome 8p22 candidates is crucial for understanding prostate cancer genetics.